Wiktor Szewczuk

Wiktor Szewczuk

Auto-generated profile, based on publicly available information

Wiktor Szewczuk

Department of Pathology, Military Institute of Medicine, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2007 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
RJRyszard Jeczen
Ryszard Jeczen
DSDanuta Skomra
Danuta Skomra
MCMarek Cybulski
Marek Cybulski
RSRegine Schneider-Stock
Regine Schneider-Stock
WSWiktor Szewczuk
Wiktor Szewczuk
Andrzej SemczukAndrzej Semczuk
Andrzej Semczuk

1 March 2008 in Pathology - Research and Practice
Verified
Journal Article
Closed access
Andrzej SemczukAndrzej Semczuk
Andrzej Semczuk
DSDanuta Skomra
Danuta Skomra
MCMonika Chyżyńska
Monika Chyżyńska
WSWiktor Szewczuk
Wiktor Szewczuk
POPiotr Olcha
Piotr Olcha
EKElżbieta Korobowicz
Elżbieta Korobowicz

5 May 2010 in Oncology
Verified
Journal Article
Closed access
ASAndrzej Semczuk
Andrzej Semczuk
RSRegine Schneider-Stock
Regine Schneider-Stock
WSWiktor Szewczuk
Wiktor Szewczuk
Alterations within the TP53 tumor suppressor belong to the most common genetic features reported in various human neoplasms, including endometrial cancer. In this article, the prevalence of allelic loss at the TP53 locus in primary human endometrial carcinomas (ECs) is discussed. Furthermore, we reviewed the role of allelic imbalance at 17p13.1 in metastatic human ECs on the basis of a literature review and on recently published data ascertained by our laboratory staff.

30 June 2009 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
WSWiktor Szewczuk
Wiktor Szewczuk
DSDanuta Skomra
Danuta Skomra
MCMarek Cybulski
Marek Cybulski
DPDorota Prządka-Rabaniuk
Dorota Prządka-Rabaniuk
AFAgata Filip
Agata Filip
Andrzej SemczukAndrzej Semczuk
Andrzej Semczuk

23 December 2019 in Journal of International Medical Research
Verified
Journal Article
Open access
PDF file
WSWiktor Szewczuk
Wiktor Szewczuk
OSOksana Szewczuk
Oksana Szewczuk
KCKrzysztof Czajkowski
Krzysztof Czajkowski
BGBartłomiej Grala
Bartłomiej Grala
Andrzej SemczukAndrzej Semczuk
Andrzej Semczuk
Ovarian adult-type granulosa cell tumors are often associated with endometrial hyperplasia or even uterine cancer. Herein, we present a case report of a 65-year-old female patient who had undergone curettage of the uterine cavity several times due to abnormal and irregular uterine bleeding. Owing to recurrent episodes of vaginal bleeding as well as ineffective pharmacological treatment of simple endometrial hyperplasia without atypia, the patient underwent a laparoscopically-assisted vaginal hysterectomy. Owing to an enlarged right ovary with bluish color, intra-operative pathological examination was immediately performed. Surprisingly, an ovarian adult-type granulosa cell tumor was diagnosed, and the surgery was extended to pelvic lymphadenectomy and omentectomy. Immunohistochemical staining with selected antibodies (Arginase 2, Nidogen 2, BAF250a/ARID1A, GPR30, SF-1/NR5A, and 1LRH-2E1/NR5A2) was also performed. In conclusion, in cases of recurrent vaginal bleeding concomitant with endometrial hyperplasia, the existence of rare ovarian tumors connected with extensive estrogenic stimulation must be taken into account. Immunostaining with selected antibodies (Arginase 2, Nidogen 2, ARID1A, or GPR30) may help elucidate the possible molecular mechanisms associated with the BAF250a/development of various ovarian/endometrial abnormalities.